Board approved scheduled medicines list for endorsed optometrists

Transition arrangements: The revised list below is published to allow practitioners to be familiar with the list before it comes into effect. This list will be in effect from 10 September 2018, until then the list in Table 1 of the Endorsement for scheduled medicines registration standard is still in effect.

The revised list with highlighted changes from the current list is found here. (15.5 KB,DOCX)

 

NEW Guidelines for use of scheduled medicines: Appendix B

Below is the Board-approved list of topical schedule 2,3 and 4 medicines that optometrists with a scheduled medicines endorsement are qualified to administer, obtain, prescribe, supply or use for the purposes of the practice of optometry, found in Appendix B of the Board’s Guidelines for use of scheduled medicines.1

This list will be in effect on 10 September 2018 and should be read in conjunction with the NEW Endorsement for scheduled medicines registration standard and NEW Guidelines for use of scheduled medicines.

Schedule 2 Pharmacy Medicine

Anti-infectives

Anti-inflammatories

Decongestants/
anti-allergics

Miotics, mydriatics
and cycloplegics

Dibromopropamidine

Propamidine

Antazoline

Azelastine

Ketotifen

Levocabastine

Lodoxamide

Naphazoline

Pheniramine

Sodium Cromoglycate

Phenylephrine <1%

 

Schedule 3 Pharmacist Only Medicine

Anti-infectives

Chloramphenicol

 

Schedule 4 Prescription Only Medicine

Anti-infectives

Anti-inflammatories

Decongestants/
anti-allergics

Anti-glaucomas

Aciclovir

Azithromycin

Bacitracin

Cephazolin

Ciprofloxacin

Framycetin

Gentamicin

Gramicidin

Neomycin

Ofloxacin

Polymyxin

Tetracycline

Tobramycin

Cyclosporin

Dexamethasone

Diclofenac

Fluorometholone

Flurbiprofen

Hydrocortisone

Ketorolac

Loteprednol

Prednisolone

Olopatadine

Apraclonidine

Betaxolol

Bimatoprost

Brimonidine

Brinzolamide

Dorzolamide

Latanoprost

Pilocarpine

Tafluprost

Timolol

Travoprost

Miotics, mydriatics
and cycloplegics

Local anaesthetics

Atropine

Cyclopentolate

Homatropine

Pilocarpine

Phenylephrine

Tropicamide

Amethocaine

Lignocaine

Oxybuprocaine

Proxymetacaine

 


1 Registered optometrists with a scheduled medicines endorsement must be familiar and comply with the current requirements in the jurisdictions in which they practice. Advice on the legal requirements in a particular state or territory may be obtained from the relevant authority found at www.tga.gov.au/contacts-stateterritory-drugs-poisons-units. For the safe and effective use of a medicine, endorsed optometrists must also be familiar with TGA approved indications found in the product information. The product information may be found at www.ebs.tga.gov.au.

 

 
 
Page reviewed 18/06/2018